Biotoxtech Co Stock Working Capital
| 086040 Stock | KRW 5,600 50.00 0.88% |
Biotoxtech Co fundamentals help investors to digest information that contributes to Biotoxtech's financial success or failures. It also enables traders to predict the movement of Biotoxtech Stock. The fundamental analysis module provides a way to measure Biotoxtech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotoxtech stock.
Biotoxtech |
Biotoxtech Co Company Working Capital Analysis
Biotoxtech's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Biotoxtech Working Capital | (4.75 B) |
Most of Biotoxtech's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotoxtech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
In accordance with the company's disclosures, Biotoxtech Co has a Working Capital of (4.75 Billion). This is much lower than that of the Life Sciences Tools & Services sector and significantly lower than that of the Health Care industry. The working capital for all Republic of Korea stocks is notably higher than that of the company.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
| All Next | Launch Module |
Biotoxtech Fundamentals
| Return On Equity | 13.27 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 156.1 B | |||
| Shares Outstanding | 14.56 M | |||
| Shares Owned By Insiders | 26.95 % | |||
| Shares Owned By Institutions | 0.68 % | |||
| Price To Earning | 47.60 X | |||
| Price To Sales | 3.12 X | |||
| Revenue | 34.09 B | |||
| Gross Profit | 6.4 B | |||
| EBITDA | 5.67 B | |||
| Net Income | 6.98 B | |||
| Cash And Equivalents | 18.59 B | |||
| Cash Per Share | 803.72 X | |||
| Total Debt | 2.01 B | |||
| Debt To Equity | 47.30 % | |||
| Current Ratio | 0.71 X | |||
| Book Value Per Share | 1,604 X | |||
| Cash Flow From Operations | 4.35 B | |||
| Target Price | 15000.0 | |||
| Beta | 0.84 | |||
| Market Capitalization | 115.73 B | |||
| Total Asset | 90.74 B | |||
| Retained Earnings | (4.82 B) | |||
| Working Capital | (4.75 B) | |||
| Current Asset | 13.46 B | |||
| Current Liabilities | 18.21 B | |||
| Z Score | 34.2 | |||
| Net Asset | 90.74 B |
About Biotoxtech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotoxtech Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotoxtech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotoxtech Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biotoxtech in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biotoxtech's short interest history, or implied volatility extrapolated from Biotoxtech options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biotoxtech Co. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the Biotoxtech information on this page should be used as a complementary analysis to other Biotoxtech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Complementary Tools for Biotoxtech Stock analysis
When running Biotoxtech's price analysis, check to measure Biotoxtech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotoxtech is operating at the current time. Most of Biotoxtech's value examination focuses on studying past and present price action to predict the probability of Biotoxtech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotoxtech's price. Additionally, you may evaluate how the addition of Biotoxtech to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Commodity Directory Find actively traded commodities issued by global exchanges |